Benchmark Maintains Buy on BlueLinx Hldgs, Lowers Price Target to $120
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Benchmark analyst Reuben Garner maintains BlueLinx Hldgs (NYSE:BXC) with a Buy and lowers the price target from $135 to $120.
Benchmark analyst Reuben Garner maintains BlueLinx Hldgs (NYSE:BXC) with a Buy and lowers the price target from $135 to $120.